RESEARCH ARTICLE MICROBIOLOGY MERSCoV endoribonuclease accessory proteins jointly evade host innate immunity infection lung nasal epithelial cells Courtney E Comarab12 Noam A Cohendf Anthony R Fehrce Jessica Pfannenstielc Ethan Doergerc David M Rennerab Li Hui Tand Stanley Perlmane Susan R Weissab3 Clayton J Otterab2 Edited Peter Palese Icahn School Medicine Mount Sinai New York NY received December 24 2021 accepted April 13 2022 Middle East respiratory syndrome coronavirus MERSCoV emerged humans 2012 causing highly lethal respiratory disease The severity disease MERSCoV adept antagonizing early innate immune pathways interferon IFN production signaling protein kinase R PKR oligoadenylate synthetaseribonuclease L OASRNase Lactivated response viral double stranded RNA dsRNA generated genome replication This contrast severe acute respiratory syndrome CoV2 SARSCoV2 recently reported activate PKR RNase L extent IFN signaling We previously MERSCoV accessory proteins NS4a dsRNA binding protein NS4b phos phodiesterase weakly suppress pathways ablation minimal effect virus replication Here investigated antagonist effects conserved coronavirus endoribonuclease EndoU combination NS4a NS4b Inactiva tion EndoU catalytic activity recombinant MERSCoV caused little effect activation innate immune pathways infection However infec tion recombinant viruses containing combined mutations inactivation EndoU deletion NS4a inactivation NS4b phosphodiesterase promoted robust activation dsRNAinduced innate immune pathways This resulted tenfold attenuation replication human lungderived A549 primary nasal cells Furthermore replication recombinant viruses rescued level wildtype MERSCoV knockout host immune mediators MAVS PKR RNase L Thus EndoU accessory proteins NS4a NS4b suppress dsRNA induced innate immunity MERSCoV infection order optimize viral replication MERSCoV j endonuclease U j innate immune antagonism j RNase L j PKR Middle East respiratory syndrome coronavirus MERSCoV ﬁrst emerged 2012 Saudi Arabia 1 second zoonotic coronaviruses emerge humans 21st century following severe acute respiratory syndrome coronavirus SARSCoV 2002 preceding SARSCoV2 2019 MERSCoV highly pathogenic betacoronavirus merbeco lineage caused 890 deaths 2585 laboratoryconﬁrmed cases February 2022 according World Health Organization amounting case fatality rate 34 MERSCoV circulates natural reservoir dromedary camels closely related viruses bats suggesting MERSCoV descended bat virus 27 Coronavirus genomes large positivesense singlestranded RNA ssRNA 50 cap 30 polyA tail Speciﬁcally MERSCoV genome 30119 nucleotides length The 50 twothirds coronavirus genome encodes conserved replicase proteins ORF1a ORF1b involved processes RNA replication transcription RNA capping processing proteolytic processing replicase pro teins host innate immune antagonism The 30 onethird genome encodes structural genes unique lineagespeciﬁc accessory genes nec essary viral replication play important roles immune evasion viral pathogenesis Early infection coronaviruses establish transcriptionreplication complexes endoplasmic reticulumassociated doublemembrane vesicles Replication coronavirus genome RNA transcription messenger RNAs mRNAs takes place complexes generates doublestranded RNA dsRNA intermediates This dsRNA provides pathogen associate molecular pattern PAMP detected different host pattern recognition receptors PRRs leading activation innate immune antiviral pathways Melanoma differentiationassociated protein 5 Signiﬁcance Middle East respiratory syndrome coronavirus MERSCoV causes highly lethal respiratory disease MERSCoV encodes innate immune antagonists including accessory proteins NS4a NS4b unique merbeco lineage betacoronaviruses nsp15 protein endoribonuclease EndoU conserved coronaviruses While mutation antagonist protein little effect innate immunity infections recombinant MERSCoVs mutations EndoU combination NS4a NS4b activate innate signaling pathways attenuated replication Our data indicate EndoU accessory proteins NS4a NS4b suppress innate immunity MERSCoV infection optimize viral replication This contrast SARSCoV2 activates pathways vulnerable host innate immune responses This article PNAS Direct Submission Copyright 2022 Authors Published PNAS This article distributed Creative Commons AttributionNonCommercialNoDerivatives License 40 CC BYNCND 1Present addresses Clinical Microbiology Laboratory Hospital University Pennsylvania Philadelphia PA 19104 Infectious Disease Diagnostics Laboratory Childrens Hospital Philadelphia Philadelphia PA 19104 Department Pathology Laboratory Medicine Perelman School Medicine University Pennsylvania Philadelphia PA 19104 2CEC CJO contributed equally work 3To correspondence addressed Email weisssrpennmedicineupennedu This article contains supporting information online httpwwwpnasorglookupsuppldoi101073pnas 2123208119DCSupplemental Published May 20 2022 PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 1 12 MDA5 PRR detects coronavirus dsRNA 8 induces signaling mitochondrial antiviralsignaling protein MAVS leads activation interferon IFN regulatory factors transcription type I III IFNs 9 IFNs produced secreted infected cell signal autocrine paracrine fashion Downstream Janus kinase JAKsignal transducer activator transcription STAT signaling phosphorylation leads expression IFNstimulated genes ISGs produce antiviral state Protein kinase R PKR cytoplas mic PRR activated dsRNA Upon sensing dsRNA PKR autophosphorylates phosphorylates translation initia tion factor eIF2a leading translational arrest 10 Oligoade nylate synthetases OAS13 detecting dsRNA produce 250oligoadenylates 25A activate host enzyme ribo nuclease L RNase L cleaves viral host ssRNA 11 12 Activation pathways leads restriction virus replication spread RNase L PKR activation promote IFN production cellular stress inﬂammation andor apoptotic death 1316 Many viruses including coronavi ruses evolved mechanisms counteracting pathways Importantly pathways acti vated independently 1719 IFN signaling inhibited infection case viruses OASRNase L PKR pathways acti vated In addition OASs PKR ISGs PKR OASRNase L pathways upregulated IFN Coronavirus accessory proteins contribute differences lineages betacoronaviruses The merbeco virus MERSCoV particularly efﬁcient shutting host innate immune pathways including IFN signaling PKR OASRNase L sarbecovirus SARSCoV2 activates PKR RNase L weakly activates IFNs 18 Two acces sory proteins encoded MERSCoV shown play important roles innate immune antagonism 2022 NS4a NS4b encoded mRNA4 ORF4a ORF4b respectively NS4a dsRNAbinding protein reported block IFN induction PKR acti vation 21 2327 NS4b functional domains phosphodiesterase PDE amino terminal nuclear localization signal NLS The PDE degrades 25A preventing activation RNase L weakly inhibits IFN production 21 22 The amino terminal NLS confers expression nucleus reported block NFκB transloca tion nucleus 22 2831 Previously recombinant mutant MERSCoV ablated NS4a expression induced low levels phosphorylated PKR detectable phosphorylation eIF2a lowlevel type I III IFN expression 21 recombinant MERSCoV inactivated NS4b PDE led mild activation RNase L IFN induction 21 22 Notably embecovi ruses HCoVOC43 murine coronavirus MHV sarbeco lineages example SARSCoV2 encode dsRNAbinding protein While sar becoviruses express PDE embecoviruses encode PDE NS2 protein However contrast NS4b PDE lacks NLS expressed completely cytoplasm 32 These differences accessory proteins CoVs pathogenesis immune evasion example human coronavirus likely contribute differences Nonstructural protein 15 nsp15 conserved coronavirus replicase protein encoded ORF1b contains endoribonu clease EndoU domain catalytic histidine residues Murine coronavirus MHV EndoU shown limit dsRNA accumulation consequently reduces IFN production signaling activation OASRNase L PKR pathways infection murine bone marrowderived mac rophages 33 34 While exact mechanism action EndoU completely understood different mechanisms reported One report concludes EndoU cleaves genomic RNA limit production dsRNA 35 concludes EndoU degrades polyU 50 end negative strand RNA eliminating PAMP sensors 36 The role MERSCoV EndoU activity antagonizing innate immu nity examined infection human cells Using group recombinant mutant viruses investi gated role EndoU combination NS4a NS4b innate immune antagonism MERSCoV infection In addition investigating immune evasion line A549DPP4 MERSCoV lungderived cell expresses MERSCoV receptor dipeptidyl peptidase 4 Calu3 extended study hostpathogen immune interactions primary patientderived nasal epithelial cells airliquid interface cultures Our ﬁndings indicate MERS CoV EndoU accessory proteins effectively shut innate immune pathways optimize replication Results Construction Recombinant MERSCoVs Replication Kinetics VeroCCL81 A549DPP4 Calu3 Cells In order study effects EndoU activity dsRNAinduced antivi ral innate immune pathways MERSCoV infection recombinant mutants constructed Lambda Red recombination bacterial artiﬁcial chromosome BAC encodes fulllength MERSCoV genome 37 Recombinant viruses summarized Fig 1A MERSCoV nsp15H231A amino acid substitution inactivating EndoU MERSCoVΔNS4a interruption NS4a expression insertion termination codons positions 11 12 MERSCoVNS4bH182R amino acid substitution inacti vating PDE double mutants MERSCoVnsp15H231A ΔNS4a MERSCoVnsp15H231ANS4bH182R We conﬁrmed Western blot MERSΔNS4a MERSnsp15H231A ΔNS4a infection produced undetectable expression NS4a pro tein Fig 1B As observed previously NS4bH182R mutant expressed NS4b wildtype WT MERSCoV Fig 1B 21 We compared replication mutant viruses WT MERSCoV initially African Green Monkey kidney Vero CCL81 Vero cells defective IFN production Cells infected multiplicity infection MOI 1 supernatant samples harvested 2 24 48 72 h postinfection hpi Quantiﬁcation infectious virus completed standard viral plaque assay Vero cells previously described 18 Mutant viruses replicated similar levels WT MERSCoV inde pendent experiments Fig 1C indicating absence inherent replication defects To investigate effects dsRNAinduced innate immune activity replication viruses A549DPP4 cells intact IFN PKR RNase L pathways infected MOI 1 infectious virus quantiﬁed At 48 72 hpi observed approximate 1 log10 plaqueforming units mL decrease infectious virus produced MERS nsp15H231AΔNS4a MERSnsp15H231ANS4bH182R mutants compared WT MERSCoV reached statistical signiﬁcance Fig 1D Interestingly mutation EndoU catalytic site MERSnsp15H231A resulted small statistically signiﬁcant 2 12 httpsdoiorg101073pnas2123208119 pnasorg A C E B D F Fig 1 Recombinant MERSCoV design replication kinetics A Diagram MERSCoV genome including replicase locus encoding 16 nsps structural genes accessory genes shown diagram recombinant mutant constructed BAC reverse genetics B A549DPP4 cells infected MOI 5 indicated viruses protein lysates harvested 24 hpi Expression NS4a NS4b deter mined SDSPAGE Western blot C Vero cells infected triplicate MOI 1 indicated viruses Supernatants collected indicated hpi infectious virus quantiﬁed plaque assay D A549DPP4 cells infected triplicate indicated viruses MOI 1 replication quantiﬁed C Data C D representative independent experiments E A549DPP4 F Calu3 cells infected triplicate indicated viruses MOI 01 replication quantiﬁed C All data CF displayed means SD The dotted line CF indicates limit detection plaque assay Statistical signiﬁcance recombinant virus compared WT MERSCoV calculated repeated measures twoway ANOVA P 005 P 001 P 0001 P 00001 Data statistically signiﬁcant labeled ns defect infectious virus production No differences noted MERSΔNS4a MERSNS4bH182R replication This consistent previous ﬁnding mild effects viral replication mutant lacking expression accessory proteins To investigate replication defect A549DPP4 cells infected MOI 01 MERSnsp15H231A MERS nsp15H231AΔNS4a MERSnsp15H231ANS4bH182R Fig 1E The attenuation viruses compared WT MERSCoV MOI 01 similar observed MOI Furthermore replication defects MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R compared WT MERSCoV MOI 01 observed Calu3 cells different lung PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 3 12 carcinoma cell line Thus loss EndoU activity combined loss NS4a expression NS4b PDE activity led attenuation virus replication lungderived cells lines intact innate immune responses inactivated dsRNA Accumulation Is Increased When EndoU Is Inactive MERSCoV Infection Next sought examine pro duction dsRNA infection MERSCoV recombi nants containing catalytic inactivation mutations EndoU nsp15H231A compared WT MERSCoV Detection dsRNA assessed immunoﬂuorescence IF assay monoclonal antibody J2 directed dsRNA imaged wideﬁeld microscopy In independent experi ments observed increased expression dsRNA EndoU including infection MERSnsp15H231A MERSnsp15H231AΔNS4a compared WT MERSCoV Fig 2A consistent previous ﬁndings inactivation MHV EndoU 33 36 To quantify observation extend MERSCoV mutants infected A549DPP4 MOI ﬁve glass coverslips ﬁxed 4 paraformaldehyde We performed combined ﬂuorescent situ hybridization FISHIF J2 antibody detect dsRNA antiserum viral primase nsp8 component viral polymerase complex marker virus replicationtranscription complexes 38 oligonucleotide probes detect nucleocapsid NssRNA deﬁne cytoplasm We observed brighter staining dsRNA MERSnsp15H231A MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R compared WT MERSCoV 48 hpi Fig 2B Fiji software quantiﬁcation described Materials Methods Brieﬂy extensive celltocell fusion syncytia unable infected cells quantiﬁcation To quantify line individual dsRNA outlined infected areas images syncytia sin gle cells nucleocapsid RNA staining deﬁne cyto plasm called regions ROIs We measured mean gray value MGV ﬂuorescence signal dsRNA nsp8 ROI recorded ratio dsRNA MGV nsp8 MGV ROI These ratios com pared infection mutant WT viruses 48 A549DPP4 cells Fig 2C We observed statistically hpi signiﬁcant increases dsRNAnsp8 ratios MERSnsp15H231A MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R compared WT MERSCoV MERSΔNS4a MERSNS4bH182R 48 hpi MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R Induce IFN ISG Expression To investigate activation type IIII IFN pathways increased infection absence EndoU activity infected A549DPP4 cells MOI 5 panel MERSCoV recombinant mutant viruses collected total intracellular RNA 24 48 hpi Fig 3 We qRTPCR quantify mRNA expres sion select IFN genes IFNL1 IFNB ISGs com pared mock infected cells We minimal expression IFNs ISGs mock infected cells infection viruses 24 hpi However 48 hpi expression IFNL1 IFNB mock infected remains minimal WT infected cells induced modest variable extents cells infected single mutants compared WT infected cells contrast IFN mRNAs ISG mRNAs signiﬁ cantly induced doublemutant MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182Rinfected cells compared WT MERSCoV infection Similarly expression mock infected select ISG mRNAs IFIH1 OAS2 IFIT1 signiﬁcantly increased RNA cells infected MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R compared RNA WT MERSCoVinfected cells Addi tionally ISG expression signiﬁcantly increased infection single mutant MERSnsp15H231A MERS ΔNS4a infection compared WTMERSCoV 48 hpi doublemutant infected cells RNase L PKR pathways activated MERSCoV double mutants We investigated RNase L activated absence EndoU catalytic activity combina tion loss NS4a expression NS4b PDE activity Thus infected A549DPP4 cells single doublemutant MERSCoV WT MERSCoV MOI 5 har vested total cellular RNA 24 48 hpi determined RNase L activation cleavage ribosomal RNA rRNA indicated Agilent RNA Nano 6000 assay Fig 4A Sindbis virus SINV unrelated alphavirus robustly activates RNase L served positive control As reported previously RNase L weakly activated infection MERSNS4bH182R absence PDE activity MERSΔNS4a 21 22 We inactivation EndoU MERSnsp15H231A lead strong RNase L activation A549DPP4 cells MERS nsp15H231A ΔNS4a infection weakly activated RNase L evidenced slight 28S 18S rRNA degradation In contrast MERS nsp15H231ANS4bH182R infection promoted rRNA degradation 48 hpi indicating robust RNase L activation absence EndoU NS4b PDE enzymatic activities This contrasts previous ﬁndings MHV infection bone marrowderived macrophages inactivation PDE EndoU results robust activation RNase L extreme attenuation replication discussed We examined induction PKR pathway EndoU inactivated combination loss NS4a expression Thus A549DPP4 cells infected single double MERSCoV mutants MOI 5 protein lysates harvested 24 48 hpi processed sodium dodecyl sulfate polyacrylamide gel electrophoresis SDSPAGE followed Western blotting detection PKR activation Fig 4B As observed previously PKR activa tion detected infection WT MERSCoV MERSΔNS4a infection induced weak phosphoryla tion PKR downstream mediator eIF2a 21 23 25 In addition inactivation EndoU infection MERSnsp15H231A induce strong activation PKR Only mild phosphorylation PKR observed 48 hpi late infection earlier 24hpi time point phosphorylation eIF2a detected However dur ing infection doublemutant MERSnsp15H231AΔNS4a strong activation PKR observed 24 48 hpi indicated phosphorylation PKR eIF2a Key Host Immune Mediators Rescues Knockout Attenuation Observed MERSCoV Recombinants Due replication defects observed A549DPP4 cells strong innate immunestimulatory phenotype observed MERS nsp15H231AΔNS4a MERSnsp15H231ANS4bH182R infec tion sought determine knockout KO key mediator dsRNAinduced antiviral path ways rescue replication recombinant viruses We previously constructed A549DPP4 RNase L KO cells 21 additionally generated A549DPP4 MAVS KO cells A549DPP4 PKR KO cells abrogate host RNase L 4 12 httpsdoiorg101073pnas2123208119 pnasorg Fig 2 The dsRNA expression increased EndoU inactive MERSCoV infection A Representative dsRNA staining MERSCoV infection A549DPP4 cells infected MOI 5 ﬁxed 24 48 hpi 4 paraformaldehyde subjected IF detect dsRNA 20 wideﬁeld micros copy Nuclei stained Hoechst shown blue dsRNA stained J2 shown white Scale bar 50 μm B Representative images quanti ﬁcation dsRNA A549DPP4 cells mock infected 24 hpi MERSCoV infected MOI 5 ﬁxed 48 hpi shown single channels dsRNA nsp8 NssRNA DAPI Merged image shows DAPI blue nsp8 magenta dsRNA green Scale bar 50 μm The dsRNA nsp8 stained IF J2 antinsp8 serum NssRNA stained FISH nuclei stained Hoechst DAPI C The dsRNA quantiﬁed graphing ratio dsRNA MGV nsp8 MGV infected ROI An ROI deﬁned thresholding Otsu method NssRNA staining Fiji Each dot repre sents ratio dsRNAnsp8 ROI Five seven representative ﬁelds wideﬁeld microscopy 20 15 zoom analyzed condition Data shown representative independent experiments mean plus SD shown Statistical signiﬁcance compared WT MERSCoV determined oneway ANOVA P 005 P 00001 Data statistically signiﬁcant labeled IFN PKR pathways respectively KO host immune mediators conﬁrmed Western blotting Fig 5A We conﬁrmed KO IFN pathway A549DPP4 MAVS KO cells qRTPCR context Sendai virus Cantell strain infection 39 paramyxovirus induces high levels IFNs showing type I IFNB IFNL1 completely eliminated infected A549DPP4 MAVS KO cells compared WT A549DPP4 cells Fig 5B We compared rep lication WT MERSCoV double mutants MERS nsp15H231AΔNS4a MERSnsp15H231ANS4bH182R WT PKR KO MAVS KO A549DPP4 cells previously described A549DPP4 RNase L KO cells Fig 5C expressions type III 21 Cells infected MOI 1 supernatant sam ples harvested 48 hpi Quantiﬁcation infectious virus completed plaque assay In WT A549DPP4 cells observed signiﬁcant attenuation viral replication viral recombinants compared WT MERSCoV expected Fig 1C KO PKR A549DPP4 cells rescued MERS nsp15H231AΔNS4a replication WT MERSCoV levels MERSnsp15H231ANS4bH182R remained attenuated consistent strong activation PKR pathway MERSnsp15H231AΔNS4a Fig 4B KO RNase L A549DPP4 cells rescued replication MERSnsp15H231A NS4bH182R lacking PDE activity MERSnsp15H231A ΔNS4a remained attenuated consistent observation PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 5 12 Fig 3 MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R induce IFNISG expression A549DPP4 cells A549DPP4 cells mock infected infected triplicate MOI 5 Total RNA harvested 24 48 hpi expression IFNL1 IFNB IFIH1 OAS2 IFIT1 mRNAs quantiﬁed cid2ΔΔCT formula Data displayed means SD Data representative qRTPCR expressed fold change mock infected 2 independent experiments Statistical signiﬁcance compared WT MERSCoV calculated twoway ANOVA P 005 P 001 P 0001 P 00001 Data statistically signiﬁcant labeled MERSnsp15H231AΔNS4a stronger activation RNase L MERSnsp15H231ANS4bH182R Fig 4A In MAVS KO cells replication doublemutant recombinant viruses MERS nsp15H231ANS4bH182R rescued WT MERSCoV levels This suggests particular importance IFN pathway limit ing MERSCoV replication A549DPP4 cells elimination pathway MAVS KO sufﬁcient restore replication recombinant viruses WT levels Infection Primary Nasal Epithelial Cell Cultures Mutant MERSCoV Recombinants Reproduces Attenuation ImmuneStimulatory Phenotype Observed A549DPP4 Cells Given robust activation dsRNAinduced antiviral innate immune pathways observe A549DPP4 cells infection MERSnsp15H231AΔNS4a MERS nsp15H231ANS4bH182R sought compare viral mutants WT MERSCoV primary nasal epithelial cell culture We grew differentiated patientderived nasal samples airliquid interface ALI 40 order recapitu late vivo airway epithelium terms cell types including epithelial cells beating cilia mucusproducing goblet cells targeted MERSCoV 41 42 We previously showed nasal ALI cultures productively infected MERSCoV 18 To investigate kinetics viral replication innate immune induction cultures infected nasal ALI cultures derived independent donors WT MERSCoV MERSnsp15H231AΔNS4a MOI 5 We collected airway surface liquid ASL 48 96 144 hpi collected total cellular RNA 48 96 hpi Shed virus ASL samples quantiﬁed plaque assay total RNA qRTPCR analysis IFN ISG expression time point We observed signiﬁcant reductions viral repli cation MERSnsp15H231AΔNS4a compared WT MERS CoV donors late time points Fig 6A consistent observations A549DPP4 cells MERSnsp15H231AΔNS4a infec tion induced signiﬁcantly IFN IFNL1 IFNB representative ISG IFIT1 expression compared WT MERS CoV nasal ALI cultures Fig 6B We infected nasal ALI cultures derived additional donors WT MERS CoV MERSnsp15H231AΔNS4a MERSnsp15H231A NS4bH182R query immunestimulatory phenotype double mutants observed A549DPP4 cells replicated primary epithelial culture We observed decreases viral shedding recombinant viruses compared WT MERSCoV donors 72 hpi Fig 6C hypothesize defect viral replication ampliﬁed cultures later time points observed Fig 6A We observed signiﬁcantly increased induction IFNB IFNL1 mRNA expression nasal ALIs infected recombinant viruses compared WT MERSCoV signiﬁcantly increased induction ISG IFIT1 Fig 6D We observed vari ability IFN responses donors likely inherent differ ences donors permissiveness infection host immune response Overall increased innate immune responses observed infection A549DPP4 cells MERSnsp15H231AΔNS4a MERS nsp15H231ANS4bH182R compared WT MERSCoV attenuation viral recombinants replicated pri mary nasal epithelial cultures This highlights physiologic innate immune evasion MERSCoV relevance upper airway data demonstrate Discussion The timing IFN response shown crucial fac tor determining outcome MERSCoV infection 6 12 httpsdoiorg101073pnas2123208119 pnasorg Fig 4 RNase L PKR activated absence EndoU activity combined loss accessory proteins MERSCoV infection A A549DPP4 cells mock infected infected MOI 5 total cellular RNA harvested 24 48 hpi The rRNA degradation assessed Agilent Bioanalyzer 28S 18S rRNA positions indicated Data representative independent experiments B A549DPP4 cells mock infected infected MOI 5 cell lysates harvested 24 48 hpi Proteins separated SDSPAGE immunoblotted antibodies phosphorylated PKR pPKR PKR phosphorylated eIF2a peIF2a eIF2a MERSCoV nucleocapsid N glyceraldehyde3phosphate dehydroge nase GAPDH Data representative 24 hpi 48 hpi independent experiments mouse model 43 While administration type I IFN 1 d post infection protected mice lethal infection delayed treatment IFN failed inhibit viral replication resulted increased ISG inﬂammatory cytokine gene expression mice eventually succumbing lethal pneumo nia 43 More recently COVID19 pandemic vari ous genomewide association studies identiﬁed variants genes innate immune antiviral functions asso ciated COVID19 susceptibility moresevere clinical phenotypes respiratory failure These include genes encoding type I IFN receptor IFNAR2 cytokines antiviral signaling pathways TYK2 250oligoadenylate synthetases OAS key induction RNase L reviewed ref 44 This makes crucial understand coronavirus antagonist proteins interact host antiviral pathways delay prevent induction IFN related antiviral responses Coronaviruses encode multiple antagonists host innate immune responses These include replicase encoded proteins nsp15 conserved coronaviruses accessory proteins unique lineage including NS4a NS4b MERSCoV coronaviruses related merbecoviruses We MERS CoV highly effective shutting dsRNAinduced antiviral pathwaysIFN signaling OASRNase L PKRcompared coronaviruses lineages includ ing sarbecovirus SARSCoV2 Indeed WT MERS CoV induces minimal IFN ISGs fails activate OASRNase L PKR pathways activated infection SARSCoV2 18 We demonstrate expression NS4a combination NS4b conserved nsp15 lineagespeciﬁc proteins We sought build understanding interactions MERSCoV accessory proteins NS4a NS4b host dsRNAinduced innate immune pathways assessing activities combination nsp15 endoribonuclease EndoU activity shown limit accumulation dsRNA block induction IFN OASRNase L PKR context coronavirus infections includ ing murine coronavirus MHV HCoV 229E porcine epi demic diarrhea virus 33 34 45 role EndoU innate immune evasion MERSCoV infection investigated Thus understand MERS CoV antagonism innate immune pathways effects EndoU combined viral accessory PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 7 12 Fig 5 KO innate immune pathways rescues attenuation MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R A Cell lysates WT A549DPP4 MAVS KO PKR KO RNase L KO A549DPP4 collected proteins separated SDSPAGE immunoblotted antibodies MAVS PKR RNase L GADPH B WT A549DPP4 MAVS KO A549DPP4 cells infected Sendai virus MOI 5 total cellular RNA harvested 18 hpi Expression IFNL1 IFNB quantiﬁed qRTPCR CT values normalized betaactin shown fold change mock formula 2ΔΔCT Data displayed means SD C A549DPP4 cell lines WT MAVS KO PKR KO RNase L KO infected triplicate MOI 1 supernatant samples collected 48 hpi Viral replication quantiﬁed plaque assay Data displayed means SD Statistical signiﬁcance differences viral replication recombinant virus compared WT MERSCoV calculated repeated measures twoway ANOVA P 005 P 001 P 00001 Data statistically signiﬁcant labeled Data representative independent experiments proteins constructed series recombinant mutant viruses mutations single antagonist genes NS4a NS4b nsp15 combinations mutations nsp15 NS4a NS4b We combined inactivation EndoU ablation NS4a expression inactivation PDE domain NS4b caused signiﬁcant replication defect MERSCoV Fig 1 We propose MERSCoVencoded innate immune antagonist proteins play overlapping roles reducing accumulation dsRNA EndoU reducing sensing dsRNA PRRs NS4a directly antagonizing RNase L activity NS4b PDE replication mutated combination In addition direct antiviral activities dsRNAinduced innate immune pathways proapoptotic 1316 Thus hypothesize apoptosis induced earlier greater extent infection mutant viruses increased induction path ways contribute attenuation MERS CoV mutant replication leading attenuation To add physiologic relevance study infected primary cultures patientderived nasal epithelial cells WT MERSCoV double mutants The nasal cavity primary site encountered respiratory viruses like MERS CoV cultures reproduce features cell types vivo airway including mucusproducing goblet cells targeted MERSCoV ciliated epithelial cells Thus presents optimal study viral immune evasion We double mutants attenuated replication induce IFN pathway signiﬁ cantly compared WT MERSCoV culture Fig 6 Thus MERSCoV nsp15 EndoU NS4a NS4b play pivotal roles evading host innate immunity upper airways lungderived cell lines Sensing viral dsRNA ﬁrst step inducing activa tion pathways We observed increased accumula tion dsRNA Fig 2 MERSCoV infection EndoU catalytic domain inactivated similar ﬁnd ings MHV 33 34 However EndoU limits accumulation dsRNA accessory proteins required completely suppress host pathways responding dsRNA A mutant catalytically inactive increase IFNISG mRNA EndoU induced modest 8 12 httpsdoiorg101073pnas2123208119 pnasorg Fig 6 MERSnsp15H231AΔNS4a MERSnsp15H231ANS4bH182R attenuated induce IFNISGs primary nasal epithelial cells A Nasal airliquid interface ALI cultures derived independent donors infected duplicate apical cell surface MOI 5 Apically released virus col lected 48 96 144 hpi quantiﬁed plaque assay B After apically released virus collected transwell indicated time total cellular RNA collected IFN ISG mRNA expression quantiﬁed qRTPCR CT values normalized 18S rRNA shown fold change mock formula 2ΔΔCT C Nasal ALI cultures independent donors infected apically triplicate MOI 5 apically released virus collected 72 hpi quantiﬁcation viral plaque assay D After collecting apically shed virus total cellular RNA collected IFN IFIT1 mRNA expression quantiﬁed qRTPCR detailed 2ΔΔCT method Data log10 transformed displayed mean SD Statistical signiﬁcance differences calculated repeated measures twoway ANOVA P 005 P 001 P 0001 P 00001 Data statistically signiﬁcant labeled responses However double mutant inactivated EndoU combination ablation NS4a expres sion inactivation NS4b PDE catalytic activity signiﬁ cantly increased induction IFN ISG mRNA expres sion late infection lungderived A549 cells primary nasal cells Figs 3 6 As IFNISG induction expression enzymati cally active EndoU accessory protein required fully block activation PKR OASRNase L path ways While absence NS4a expression infection promoted mild activation PKR 21 infection mutant lacking NS4a EndoU activity strongly acti vated PKR pathway Fig 4B Interestingly inactivation EndoU promote signiﬁcant phosphorylation PKR indicating NS4a plays signiﬁcant role blocking induction pathway We observed robust activation RNase L infection MERSCoV expressing inactive EndoU inactive PDE However binding NS4a dsRNA OASRNase L contribute blocking activation PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 9 12 pathway suggested somewhat increased activation RNase L infection nsp15NS4a double mutant com pared single nsp15 mutant infection Fig 4A This role NS4a antagonizing OASRNase L induction infection previously appreciated In contrast current ﬁndings previously reported inactivation NS2 PDE EndoU promoted robust RNase L activation MHV 46 The differences observed MHV MERSCoV infection suggest PDE andor EndoU function differently viral systems MERSCoV NS4b localized nucleus NLS effective PDE MHV NS2 lacks NLS completely cytoplasmic In MHV expressed nucleus PDE AKAP7 unable effectively prevent activation RNase L rescue virus replication mutant MHVNS2H126R inactive PDE PDE expressed cyto plasm prevented activation RNase L restored replication MHVNS2H126R WT MHV levels 47 Additionally MHV studies carried bone marrowderived macro phages express high levels OAS genes 17 48 lead increased activation RNase L antagonists necessary prevent RNase L activation celltypedependent manner These ﬁndings highlight impor tance studying function proteins context different coronavirus infections different cell types Utilizing A549DPP4 KO cells abrogation speciﬁc immune pathways rescue viral attenuation double mutants WT MERSCoV levels While PKR KO rescued MERSnsp15H231AΔNS4a replication RNase L KO rescued MERSnsp15H231ANS4bH182R consistent recombinant viruses robustly activating pathways Interestingly replication doublemutant viruses rescued WT MERSCoV levels MAVS KO cells suggesting IFN signaling pathway particularly important limiting MERS CoV replication Indeed MERSCoV mouse model early IFN induction infection protective lethal pneu monia 43 Finally detectable enhancement replication WT MERSCoV absence MAVS Fig 5C consistent complete shutdown IFN pro duction Figs 2 6 These observations underscore importance antagonism pathways MERSCoV provide evidence host immune pathways play pivotal roles limiting CoV replication airway In addition NS4a NS4b MERSCoV genome encodes accessory proteins ORF3 ORF5 A mutant recombinant MERSCoV deletions ORF3 replication airway cells ORF5 attenuated induced increased IFN response robust inﬂammation 49 RNase L activation 22 consistent data Moreover ORF5 encoded protein identi ﬁed potential NFκB antagonist 30 49 We hypothesize deletion ORF3 ORF5 combined inactiva tion EndoU severely attenuate virus replication strongly induce innate immune responses There unanswered questions interactions virus host innate immunity infection highly pathogenic coronaviruses Different lineages betacoronaviruses encode distinct groups accessory proteins confer differences hostvirus interactions One example homologous proteins different betacoronavirus lineages PDEs merbecoviruses NS2 embecoviruses NS4b proteins differ NS4b contains NLS second function host antagonism 21 22 2831 50 The SARSCoV2 genome encodes sarbecovirus lineagespeciﬁc accessory proteins encoded ORF3a ORF3b ORF6 ORF7a ORF9b reported IFN antagonists 51 52 Most notably ORF6 encoded protein SARSCoV SARSCoV2 blocks STAT1STAT2 translocation nucleus impairing induction ISGs 53 54 However worth noting immune evasion activities SARSCoV2 accessory proteins largely characterized overexpression systems need conﬁrmed setting infection viral mutants Indeed mutant SARSCoV2 deletion ORF6 attenuated mouse model supporting role host antagonism 55 Additionally unlike WT MERSCoV WT SARSCoV2 activates dsRNAinduced innate immune pathways IFN PKR OASRNase L restricted replication RNase L 18 We hypothesize loss EndoU activity dur ing SARSCoV2 infection lead robust activation pathways detrimental effects replication pathogenesis mutation EndoU MERS CoV infection This hypothesis currently investiga tion Given high conservation CoV lineages EndoU activity nsp15 attractive antiviral drug target current future highly pathogenic coronaviruses Materials Methods Recombinant Viruses Recombinant MERSCoV viruses lambda red recombination MERSCoV BAC previously described 37 56 57 The following primers generate mutations bolded create recombinant viruses MERSnsp15H231A F 50GTGATGTTTTCATTAAGAAGTATGGCTTGGAAAACTATGCTTTTGAGGCCGTAGTCTATG GAGACTT30 R 50CGCCTAACGTAGTATGAGAGAAGTCTCCATAGACTACGGCCTCAAAAGCATAGTTTTCCA30 MERSΔNS4a amino acids 11 12 replaced stop codons F 50GAACTCTATGGATTACGTGTCTCTGCTTAATCAAATTTGATAGAAGTACCTTAACTCACC30 R 50TGTACAAACAAGTAGTATACGGTGAGTTAAGGTACTTCTATCAAATTTGATTAAGCAGAG30 MERSNS4bH182R F 50GTTCAGGGATTTTCCCTTTACCATAGTGGCCTCCCTTTACGTATGTCAATCTCTAAATTG30 R 50GTAACATCATCCAGTGCATGCAATTTAGAGATTGACATACGTAAAGGGAGGCCACTATGG30 MERSnsp15H231AΔNS4a mutations combined BAC MERSnsp15H231ANS4bH182R mutations combined BAC All ampliﬁed KanI following additions primers F 50AGGATGACGACGATAAGTAGGG30 R 50GCCAGTGTTACAACCAATTAACC30 Passage 0 P0 viruses recovered Invitrogen Lipofectamine 2000 trans fection reagent African Green Monkey VeroCCL81 cells 125 μg BAC DNA Cells monitored cytopathic effect cells supernatant har vested 5 d 7 d transfection P0 virus freeze thawed cells removed centrifugation passaged Vero CCL81 cells generate P1 stock A P2 stock generated low MOI 005 P1 stock infecting Vero CCL81 cells freeze thawed harvest cells removed supernatant stock virus experiments Quantiﬁcation infectious virus standard viral plaque assay Vero CCL81 cells 18 WT mutant MERSCoV genomes fully sequenced Illumina sequencing total RNA highly infected cell samples Consensus sequences virus gener ated aligned MERSCoV HCoVEMC2012 reference genome National Center Biotechnology Information Reference Sequence NC_0198433 All mutant viruses correct engineered mutations Sindbis virus Girdwood G100 SINV obtained Mark Heise Univer sity North Carolina Chapel Hill NC prepared previously described 58 Sendai virus obtained Carolina Lopez Washington University St Louis St Louis MO Cell Lines Vero CCL81 cells cultured Dulbeccos modiﬁed Eagles medium DMEM 10 fetal bovine serum FBS sodium pyruvate Hepes Human 10 12 httpsdoiorg101073pnas2123208119 pnasorg A549DPP4 cells cultured RPMI 1640 Gibco catalog 11875 supplemented 10 FBS penicillinstreptomycin Human Calu3 cells clone HTB55 cultured mininum essential media MEM supplemented 20 FBS antibiotics A549DPP4 A549DPP4 RNASEL KO cells previously described 21 A549DPP4 PKR KO cells constructed LentiCRISPR guide RNA sequences previously described 11 59 A549DPP4 MAVS KO cells constructed LentiCRISPR previously described 59 following guide RNAs sgMAVS2 forward 50CACCGGGGTCTCCTG GACAGGCATG30 sgMAVS2 reverse 50AAACCATGCCTGT CCAGGAGACCCC30 Nasal ALI Cultures Primary epithelial cultures derived human nasal mucosal specimens acquired residual clinical materials obtained dur ing surgery performed Department Otorhinolaryngology Head Neck Surgery University Pennsylvania informed consent obtained Patients history systemic disease immunosuppressive medications excluded previously described 32 Acquisition use nasal specimens approved University Pennsylvania Institutional Review Board protocol 800614 Cultures grown differ entiated transwell inserts previously described 32 Once fully differenti ated 6 wk postseeding basal media replaced cultures washed apically PBS times prior infection apically MERSCoV MERSCoV Infections Titration Viruses diluted serumfree DMEM added cells adsorption 1 h 37 C Cells washed times phosphatebuffered saline PBS growth curves RNA washes protein IF samples fed RPMI 2 FBS A549DPP4 DMEM 2 FBS Vero CCL81 150 μL supernatant collected times indicated stored cid280 C titration plaque assay Vero CCL81 cells previously described 18 All infections virus manipulations conducted biosafety level 3 laboratory appropriate personal pro tective equipment protocols IF FISH Staining At indicated times post infection cells ﬁxed 4 paraformaldehyde 30 min room temperature Cells washed times PBS dehydrated increasing amounts ethanol 50 70 100 5 min Samples stored 100 ethanol cid220 C overnight Cells rehydrated 70 50 ethanol 2 min washed PBS permeabilized 10 min PBS 01 TritonX100 Cells blocked PBS 01 TritonX100 2 bovine serum albumin BSA containing RNaseOUT Invitrogen catalog 10777019 30 min room temperature Primary antibodies diluted block buffer incubated room temperature 1 h Cells washed times PBS incubated room temperature 30 min secondary antibodies diluted block buffer All steps following secondary anti body addition carried dark Cells washed times PBS For IF nuclei stained DAPI diluted PBS 5 min room temperature coverslips mounted slides Invitrogen ProLong Diamond Antifade Mounting reagent analysis wideﬁeld microscopy For combined IFFISH staining cells washed times PBS stated ﬁxed 4 paraformaldehyde 10 min room tem perature Cells washed 2 standard saline citrate SSC 5 min 5 min FISH wash buffer 10 formaldehyde 2 SSC FISH probes complementary N gene MERSCoV list conjugated CAL Fluor Red 610 Stellaris custom order diluted 150 nucleasefree water Probes imaging MERSCoV NssRNA 50 3 TTTTGGATTACGTCCTCTAC AGTGTTATTTGGTGCAGCTC AAGCCCAGTGTACCAAGAG CCAGGTGGAAAGGTAAGAGG TTGGCATTAAGAGGTACACC AATTTTTCTGTCCTGTCTC CAGTTGCTTAATTCCATTCCTCCAGTGTAGTAGAAGTACCTTAACAGCCCGGAATGGGAG ATGGACCCAAACGATGCCAT TCCCAAAAGTTGAAGGAGCA AATCATTGTTAGGGTTCCG GGGCGCGAATTGTGTAACAA CCCTCAATGTGGAAGTTTTTTGATTGACTATTGCCTCCAG TTAAGCTAGAGGCTCTTGAA CTAGATCTGGAAGAGTTTCT AGATGGACCTGGAGAAGTG AAGTAGATCACCTCCTACTGGCTTGTAGTCTGTTCAGAAGCTTTACTTTGCCAGACTCAA TGATTACTTTTGGCTGCGAT AACTTTTGGTGGAAGTGCGC AGACCAAAAGCTTGCACCA GAAGATCACCAAAGTTTCCC CAGTGCCGAGTTTATTCAA TCAGCAATTTGGGGCCAACG AAAAGCACTGGCTGTAGGAG GTTTAAATTGCGACATACCC CATCATTGTTCTGATGGGT ACCGAAGGAAGTACACAGGG TCAAGTTTAATGGCTCCACT GGTTCAGACATTTGGTCTG TGAGTGATGCTACCTTGCACAACACTTGGACGGGTGCGAG ACATCAATCATTGGACCAGG Probes diluted 150 hybridization buffer 10 wtvol dextran sulfate 10 formaldehyde 2 SSC incubated samples overnight 37 C humidity chamber Samples washed FISH wash buffer 30 min 37 C nuclei stained DAPI diluted FISH wash buffer 5 min room temperature cells washed 5 min 2 SSC Coverslips mounted slides stated The dsRNA detected commercial monoclonal antibody J2 Scions 1500 nsp8 detected antinsp8 rabbit serum 1500 obtained Mark Denison Vanderbilt University Nashville TN Secondary antibodies diluted 11000 highly crossadsorbed IgG HL Invitrogen goat antimouse AF488 catalog A11029 goat antirabbit AF647 catalog A32733 Wideﬁeld microscopy Nikon Eclipse Ti2 Nikon 20 objective NikonDSQi1McU3 12bit camera Nikon Eclipse Ti2 Nikon 20 objective Hamamatsu digital camera C13440 Fiji quantiﬁcation dsRNA NssRNA staining generate mask set ting threshold Otsu method These thresholded images mask mark infected ROIs These ROIs syncytia formation marked infected areas cells singular cells The MGV ﬂuorescence sig nal dsRNA nsp8 measured ROI images infection condition Five seven ﬁelds view 20 15 zoom analyzed condition The ratio MGV dsRNA MGV nsp8 recorded individual ROI plotted GraphPad Prism software Western Blotting Cells washed icecold PBS lysates harvested indicated times post infection lysis buffer 1 Nonidet P40 2 mM EDTA 10 glycerol 150 mM NaCl 50 mM Tris HCl supplemented protease inhibitors Roche cOmplete mini EDTAfree protease inhibitor phosphatase inhibitors Roche PhosStop easy pack After 5 min lysates harvested incubated ice 20 min centrifuged 20 min 4 C supernatants mixed 31 4 Laemmli sample buffer Samples heated 95 C 5 min separated 4 15 SDSPAGE trans ferred polyvinylidene diﬂuoride membranes Blots blocked 5 non fat milk 5 BSA TBST probed antibodies listed SI Appendix Table S1 diluted block buffer Blots visualized Thermo Scientiﬁc SuperSignal west chemiluminescent substrates catalog 34095 34080 Blots probed sequentially antibodies antibody treatments stripped Thermo Scientiﬁc Restore Western blot stripping buffer 1 h room temperature catalog 21059 qRTPCR At indicated times post infection cells lysed buffer RLT Plus Qiagen RNeasy Plus 74136 RNA extracted following prescribed protocol RNA reverse transcribed complementary DNA cDNA High Capacity cDNA Reverse Transcriptase Kit Applied Biosystems The cDNA ampliﬁed speciﬁc qRTPCR primers iQ SYBR Green Supermix Bio Rad QuantStudio 3 PCR Thermo Fisher Fold changes mRNA level compared mock infected samples calculated mula 2ΔΔCtΔCt Ctgene 2 Ct18S expressed fold infected mockinfected Primer sequences listed SI Appendix Table S2 Analyses RNase LMediated rRNA Degradation RNA harvested buffer RLT plus Qiagen RNeasy Plus 74136 analyzed RNA chip Agilent Bioanalyzer Agilent RNA 6000 Nano Kit pre scribed protocol catalog 50671511 Statistical Analysis Plotting data statistical analysis performed GraphPad Prism software GraphPad Software Inc Statistical signiﬁcance determined comparing mutant viruses WT MERSCoV repeated measures twoway ANOVA viral replication curves qRTPCR oneway ANOVA dsRNA quantiﬁcation Displayed signiﬁcance determined P value P 005 P 001 P 0001 P 00001 ns signiﬁcant ﬁgures ns displayed graph Data Availability All data included manuscript andor SIAppendix ACKNOWLEDGMENTS We thank members SRW lab feedback discussion project Joshua Hatterschide University Pennsylvania assistance microscopy image analysis Rudragouda Channappanavar construction MERSnsp15H231A Nicholas Oklahoma State University Parenti performing Bioanalyzer assays Mark Heise University North Carolina Chapel Hill SINV Carolina Lopez Washington University St Louis Sendai virus This work supported NIH Grants R01AI140442 PNAS 2022 Vol 119 No 21 e2123208119 httpsdoiorg101073pnas2123208119 11 12 SRW P20 GM113117 ARF K22 AI134993 ARF P01AI060699 SP RO1AI129269 SP Department Veterans Affairs Merit Review 1I01 BX00543201 NAC SRW Penn Center Research Coronavi ruses Other Emerging Pathogens SRW startup funds University Kansas ARF DMR supported NIH grant T32 AI055400 CEC supported NIH grant T32 NS007180 Author afﬁliations aDepartment Microbiology University Pennsylvania Philadelphia PA 19104 bPenn Center Research Coronaviruses Other Emerging Pathogens Perelman School Medicine University Pennsylvania 3 1 2 A M Zaki S van Boheemen T M Bestebroer A D Osterhaus R A Fouchier Isolation novel coronavirus man pneumonia Saudi Arabia N Engl J Med 367 18141820 2012 A I Khalafalla et al MERSCoV upper respiratory tract lungs dromedary camels Saudi Arabia 20132014 Emerg Infect Dis 21 11531158 2015 C B E M Reusken et al Geographic distribution MERS coronavirus dromedary camels Africa Emerg Infect Dis 20 13701374 2014 U Wernery et al A phylogenetically distinct Middle East respiratory syndrome coronavirus detected dromedary calf closed dairy herd Dubai rising seroprevalence age Emerg Microbes Infect 4 e74 2015 V M Corman et al Rooting phylogenetic tree Middle East respiratory syndrome coronavirus characterization conspeciﬁc virus African bat J Virol 88 1129711303 2014 6 M Geldenhuys et al A metagenomic viral discovery approach identiﬁes potential zoonotic 4 5 7 8 9 novel mammalian viruses Neoromicia bats South Africa PLoS One 13 e0194527 2018 S J Anthony et al Further evidence bats evolutionary source Middle East respiratory syndrome coronavirus MBio 8 e0037317 2017 J K RothCross S J Bender S R Weiss Murine coronavirus mouse hepatitis virus recognized MDA5 induces type I interferon brain macrophagesmicroglia J Virol 82 98299838 2008 J Rehwinkel M U Gack RIGIlike receptors Their regulation roles RNA sensing Nat Rev Immunol 20 537551 2020 10 S Hur Doublestranded RNA sensors modulators innate immunity Annu Rev Immunol 37 349375 2019 11 Y Li et al Ribonuclease L mediates celllethal phenotype doublestranded RNA editing enzyme ADAR1 deﬁciency human cell line eLife 6 e25687 2017 12 R H Silverman Viral encounters 2050oligoadenylate synthetase RNase L interferon antiviral response J Virol 81 1272012729 2007 13 A Chakrabarti et al RNase L activates NLRP3 inﬂammasome viral infections Cell Host Microbe 17 466477 2015 14 R Kang D Tang PKRdependent inﬂammatory signals Sci Signal 5 pe47 2012 15 K Malathi B Dong M Gale Jr R H Silverman Small selfRNA generated RNase L ampliﬁes antiviral innate immunity Nature 448 816819 2007 16 A Zhou et al Interferon action apoptosis defective mice devoid 2050oligoadenylate 44 17 dependent RNase L EMBO J 16 63556363 1997 L D Birdwell et al Activation RNase L murine coronavirus myeloid cells dependent basal Oas gene expression independent virusinduced interferon J Virol 90 31603172 2016 18 Y Li et al SARSCoV2 induces doublestranded RNAmediated innate immune responses respiratory epithelialderived cells cardiomyocytes Proc Natl Acad Sci USA 118 e2022643118 2021 19 Y Li B Dong Z Wei R H Silverman S R Weiss Activation RNase L Egyptian Rousette bat derived RoNi7 cells dependent primarily OAS3 independent MAVS signaling MBio 10 e0241419 2019 20 E Kindler V Thiel F Weber Interaction SARS MERS coronaviruses antiviral interferon response Adv Virus Res 96 219243 2016 21 C E Comar et al Antagonism dsRNAinduced innate immune pathways NS4a NS4b 22 accessory proteins MERS coronavirus infection MBio 10 e0031919 2019 J M Thornbrough et al Middle East respiratory syndrome coronavirus NS4b protein inhibits host RNase L activation MBio 7 e00258 2016 23 K Nakagawa K Narayanan M Wada S Makino Inhibition stress granule formation Middle East respiratory syndrome coronavirus 4a accessory protein facilitates viral translation leading efﬁcient virus replication J Virol 92 0090218 2018 24 D Niemeyer et al Middle East respiratory syndrome coronavirus accessory protein 4a type I interferon antagonist J Virol 87 1248912495 2013 25 H H Rabouw et al Middle East respiratory coronavirus accessory protein 4a inhibits PKR mediated antiviral stress responses PLoS Pathog 12 e1005982 2016 26 KL Siu et al Middle East respiratory syndrome coronavirus 4a protein doublestranded RNA binding protein suppresses PACTinduced activation RIGI MDA5 innate antiviral response J Virol 88 48664876 2014 27 Y Yang et al Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production cytoplasmic nuclear targets Sci Rep 5 17554 2015 28 D K W Chu et al MERS coronaviruses camels Africa exhibit regiondependent genetic 29 diversity Proc Natl Acad Sci USA 115 31443149 2018 J Canton et al MERSCoV 4b protein interferes NFκBdependent innate immune response infection PLoS Pathog 14 e1006838 2018 30 Y Yang et al The structural accessory proteins M ORF 4a ORF 4b ORF 5 Middle East respiratory syndrome coronavirus MERSCoV potent interferon antagonists Protein Cell 4 951961 2013 Philadelphia PA 19104 cDepartment Molecular Biosciences University Kansas Lawrence KS 66045 dOtorhinolaryngologyHead Neck Surgery University Pennsylvania Philadelphia PA 19104 eDepartment Microbiology Immunology University Iowa Iowa City IA 52242 fDepartment Surgery Corporal Michael J Crescenz VA Medical Center Philadelphia PA 19104 Author contributions CEC CJO DMR NAC ARF SRW designed research CEC CJO JP ED DMR LHT performed research JP ED SP NAC ARF contributed new reagentsanalytic tools CEC CJO DMR NAC ARF SRW analyzed data CEC CJO SRW wrote paper Inc Ocugen Scientiﬁc Advisory Boards Competing statement SRW Immunome Inc NAC consults GSK AstraZeneca Novartis SanoﬁRegeneron Oyster Point Pharmaceuticals US patent Therapy Diagnostics Respiratory Infection 10881698 B2 WO20913112865 licensing agreement GeneOne Life Sciences ARF consults Deciphera Inc 31 K L Matthews C M Coleman Y van der Meer E J Snijder M B Frieman The ORF4bencoded accessory proteins Middle East respiratory syndrome coronavirus related bat coronaviruses localize nucleus inhibit innate immune signalling J Gen Virol 95 874882 2014 32 R H Silverman S R Weiss Viral phosphodiesterases antagonize doublestranded RNA signaling RNase L degrading 25A J Interferon Cytokine Res 34 455463 2014 33 E Kindler et al Early endonucleasemediated evasion RNA sensing ensures efﬁcient coronavirus replication PLoS Pathog 13 e1006195 2017 34 X Deng et al Coronavirus nonstructural protein 15 mediates evasion dsRNA sensors limits apoptosis macrophages Proc Natl Acad Sci USA 114 E4251E4260 2017 35 R Ancar et al Physiologic RNA targets reﬁned sequence speciﬁcity coronavirus EndoU RNA 26 19761999 2020 36 M Hackbart X Deng S C Baker Coronavirus endoribonuclease targets viral polyuridine sequences evade activating host sensors Proc Natl Acad Sci USA 117 80948103 2020 37 A R Fehr Bacterial artiﬁcial chromosomebased lambda red recombination ISceI homing endonuclease genetic alteration MERSCoV Methods Mol Biol 2099 5368 2020 38 A J te Velthuis S H van den Worm E J Snijder The SARScoronavirus nsp7nsp8 complex unique multimeric RNA polymerase capable novo initiation primer extension Nucleic Acids Res 40 17371747 2012 39 E Genoyer C B Lcid1opez Defective viral genomes alter Sendai virus interacts cellular trafﬁcking machinery leading heterogeneity production viral particles infected cells J Virol 93 e0157918 2019 40 M A Kohanski et al Solitary chemosensory cells primary epithelial source IL25 patients chronic rhinosinusitis nasal polyps J Allergy Clin Immunol 142 460469e7 2018 41 R J Lee et al Bitter sweet taste receptors regulate human upper respiratory innate immunity J Clin Invest 124 13931405 2014 42 R J Lee et al T2R38 taste receptor polymorphisms underlie susceptibility upper respiratory infection J Clin Invest 122 41454159 2012 43 R Channappanavar et al IFNI response timing relative virus replication determines MERS coronavirus infection outcomes J Clin Invest 129 36253639 2019 T P Velavan et al Host genetic factors determining COVID19 susceptibility severity EBioMedicine 72 103629 2021 46 45 X Deng et al Coronavirus endoribonuclease activity porcine epidemic diarrhea virus suppresses type I type III interferon responses J Virol 93 e0200018 2019 L Zhao et al Antagonism interferoninduced OASRNase L pathway murine coronavirus ns2 protein required virus replication liver pathology Cell Host Microbe 11 607616 2012 47 E Gusho et al Murine AKAP7 2050phosphodiesterase domain complement 48 inactive murine coronavirus ns2 gene MBio 5 e0131214 2014 L Zhao et al Celltypespeciﬁc activation oligoadenylate synthetaseRNase L pathway murine coronavirus J Virol 87 84088418 2013 49 V D Menachery et al MERSCoV accessory ORFs play key role infection pathogenesis MBio 8 e0066517 2017 50 S A Goldstein et al Lineage A betacoronavirus NS2 proteins homologous torovirus Berne pp1a carboxyterminal domain phosphodiesterases antagonize activation RNase L J Virol 91 e0220116 2017 51 N Chazal Coronavirus king wanted crown From common highly pathogenic SARSCoV2 key accessory genes Front Microbiol 12 682603 2021 52 C Bai Q Zhong G F Gao Overview SARSCoV2 genomeencoded proteins Sci China Life Sci 65 280294 2022 54 53 M Frieman et al Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function sequestering nuclear import factors rough endoplasmic reticulumGolgi membrane J Virol 81 98129824 2007 L Miorin et al SARSCoV2 Orf6 hijacks Nup98 block STAT nuclear import antagonize interferon signaling Proc Natl Acad Sci USA 117 2834428354 2020 J A Silvas et al Contribution SARSCoV2 accessory proteins viral pathogenicity K18 human ACE2 transgenic mice J Virol 95 e0040221 2021 F Almazcid1an et al Engineering replicationcompetent propagationdefective Middle East respiratory syndrome coronavirus vaccine candidate MBio 4 e0065013 2013 57 A R Fehr et al The nsp3 macrodomain promotes virulence mice coronavirusinduced 55 56 encephalitis J Virol 89 15231536 2015 58 M S Suthar R Shabman K Madric C Lambeth M T Heise Identiﬁcation adult mouse neurovirulence determinants Sindbis virus strain AR86 J Virol 79 42194228 2005 59 Y Li et al Activation RNase L dependent OAS3 expression infection diverse human viruses Proc Natl Acad Sci USA 113 22412246 2016 12 12 httpsdoiorg101073pnas2123208119 pnasorg